血脂代谢与胃癌发病风险相关性的病例对照研究

阎巍; 刘俊田; 刘子豪; 李世霞; 李宏

doi:10.3969/j.issn.1000-8179.2021.04.965

血脂代谢与胃癌发病风险相关性的病例对照研究

doi: 10.3969/j.issn.1000-8179.2021.04.965

阎巍^①,,
刘俊田^①, ,,
刘子豪^①,
李世霞^①,
李宏^②

1.
天津医科大学肿瘤医院预防科，国家肿瘤临床医学研究中心，天津市“肿瘤防治”重点实验室，天津市恶性肿瘤临床医学研究中心（天津市300060）
2.
天津医科大学第二医院药学部

详细信息

作者简介:
阎巍专业方向为胃部肿瘤发病、预防和干预的研究。E-mail：candy198361@163.com

通讯作者:
刘俊田 ljt641024@163.com

计量
- 文章访问数: 119
- HTML全文浏览量: 10
- PDF下载量: 26
- 被引次数: 0
出版历程
- 收稿日期: 2020-08-26
- 刊出日期: 2021-02-28

A case-control study of the correlation between lipid metabolism and gastric cancer risk

Wei Yan^{①
,},
Juntian Liu^{①
, ,},
Zihao Liu^①,
Shixia Li^①,
Hong Li^②

1.
Department of Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Center for Cancer Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China
2.
Department of Pharmacy, The Second Hospital of Tianjin Medical University, Tianjin 300211, China

More Information

Corresponding author: Juntian Liu; E-mail: ljt641024@163.com

摘要

摘要: 目的探讨血脂代谢水平与胃癌发生发展的相关性。方法选取2016年3月至2017年6月天津医科大学肿瘤医院诊治的1 072例胃癌患者与同期1 084例健康人群进行病例-对照研究，检测血清总胆固醇（total cholesterol，TC）、甘油三酯（triglyceride，TG）、高密度脂蛋白（high-density lipoprotein，HDL）和低密度脂蛋白（low-density lipoprotein，LDL）水平，采用单因素及多因素分析探讨血脂代谢水平与胃癌发病风险及临床病理特征的关系。结果胃癌患者血清中的TG、LDL水平均高于对照组，HDL低于对照组；男性胃癌患者LDL高于对照组，HDL低于对照组；女性胃癌患者血清中的TG、LDL高于对照组，HDL低于对照组（均P < 0.05）。胃癌患者HDL、LDL水平与胃癌的发病风险显著相关；男性中HDL及LDL，女性中TG、HDL及LDL分别与胃癌的发病风险显著相关。胃癌患者中，TG及TC升高常见于远端胃癌及分期较早的患者；HDL降低多见于低、未分化胃癌。男性中，TG升高多见于分期较早的患者；HDL降低多见于低、未分化胃癌。女性中，TC增高更常见于分期较早的患者（均P < 0.05）。结论胃癌患者血脂水平高于健康对照组，与胃癌的发病风险显著相关。在胃癌患者中随着疾病的进展，患者肿瘤消耗增多、营养状态持续下降，血脂水平逐渐降低。
- 胃癌 /
- 脂质代谢 /
- 风险因素 /
- 临床病理特征
Abstract: Objective To investigate the correlation between lipid metabolism and gastric cancer. Methods In total, 1, 072 patients with gastric cancer treated at Tianjin Medical University Cancer Institute and Hospital from March 2016 to June 2017 were enrolled, and 1, 084 healthy subjects were included as controls. Using univariate and multivariate analyses, the correlation between lipid metabolism and gastric cancer risk was examined; furthermore, clinicopathological characteristics, including serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels, were assessed. Results Serum TG and LDL levels were higher and HDL levels were lower in gastric cancer patients than in healthy controls. Furthermore, serum LDL levels were higher and HDL levels were lower in male gastric cancer patients than in healthy controls. Serum TG and LDL levels were higher and HDL levels were lower in female gastric cancer patients than in healthy controls (P < 0.05). In all gastric cancer patients, HDL and LDL levels were significantly correlated with gastric cancer risk. Moreover, in male patients, HDL and LDL levels were significantly correlated with gastric cancer risk. In female patients, TG, HDL, and LDL levels were significantly associated with gastric cancer risk. Among gastric cancer patients, elevated TG and TC levels were more common in patients with distal gastric cancer and an early disease stage. Decreased HDL levels were more common in patients with little differentiated/undifferentiated gastric cancer. Among male patients, increased TG levels were more common in patients with an early disease stage. Decreased HDL levels were more common in patients with little differentiated/undifferentiated gastric cancer. Among female patients, elevated TC levels were more common in early-stage cancer patients. Conclusions Serum lipid levels were higher in gastric cancer patients than in healthy controls, and they correlated with gastric cancer risk. However, as gastric cancer progresses owing to increased tumor nutrient uptake and patient's reduced nutritional status, serum lipid levels gradually decrease.
- gastric cancer /
- lipid metabolism /
- risk factors /
- clinicopathologic features

HTML全文

表 1 胃癌组和对照组血脂水平的比较

表 2 血脂水平与胃癌发病风险的相关性分析

表 3 血脂水平与胃癌患者临床病理特征的相关性

表 4 男性血脂水平与胃癌患者临床病理特征的相关性

表 5 女性血脂水平与胃癌患者临床病理特征的相关性

参考文献(18)

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
[2]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132. doi: 10.3322/caac.21338
[3]	魏丽娟, 张弛, 张寰, 等. 血脂代谢水平与乳腺癌发病风险的病例-对照研究[J]. 中华预防医学杂志, 2016, 50(12): 1091-1095. doi: 10.3760/cma.j.issn.0253-9624.2016.12.013
[4]	Choi YJ, Lee DH, Han KD, et al. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer[J]. Eur J Epidemiol, 2018, 33(11): 1077-1085. doi: 10.1007/s10654-018-0440-6
[5]	Hashimoto Y, Hamaguchi M, Obora A, et al. Impact of metabolically healthy obesity on the risk of incident gastric cancer: a populationbased cohort study[J]. BMC Endocr Disord, 2020, 20(1): 11. doi: 10.1186/s12902-019-0472-2
[6]	Zaleska M, Mozenska O, Bil J. Statins use and cancer: an update[J]. Future Oncol, 2018, 14(15): 1497-1509. doi: 10.2217/fon-2017-0543
[7]	Hager MH, Solomon KR, Freeman MR. The role of cholesterol in prostate cancer[J]. Curr Opin Clin Nutr Metab Care, 2006, 9(4): 379-385. doi: 10.1097/01.mco.0000232896.66791.62
[8]	Campos B, Centner FS, Bermejo JL, et al. Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas[J]. Am J Pathol, 2011, 178(5): 1953-1964. doi: 10.1016/j.ajpath.2011.01.051
[9]	Dong SR, Ju XL, Yang WZ. STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells[J]. Eur Rev Med Pharmacol Sci, 2019, 23(19): 8360-8370. http://www.ncbi.nlm.nih.gov/pubmed/31646566
[10]	Bibi S, Arslanhan MD, Langenfeld F, et al. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy[J]. Haematologica, 2014, 99 (3): 417-429. doi: 10.3324/haematol.2013.098442
[11]	Lindkvist B, Almquist M, Bjorge T, et al. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the metabolic syndrome and cancer project (Me-Can)[J]. Cancer Causes Control, 2013, 24(1): 107-116. doi: 10.1007/s10552-012-0096-6
[12]	Kim EH, Lee H, Chung H, et al. Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer[J]. Clin Res Hepatol Gastroenterol, 2014, 38(3): 372-378. doi: 10.1016/j.clinre.2013.11.009
[13]	石红兵, 蒋敬庭, 吴昌平. 胃癌患者血脂变化及总胆固醇的临床意义[J]. 临床肿瘤学杂志, 2011, 16(08): 686-688. doi: 10.3969/j.issn.1009-0460.2011.08.004
[14]	肖敏, 吉文晶, 孙毅. 不同病情阶段胃癌患者血清血脂水平变化分析[J]. 临床合理用药杂志, 2016, 9(28): 117-118. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201628079.htm
[15]	Kang R, Li P, Wang T, et al. Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population[J]. Sci Rep, 2016, 6: 19930. doi: 10.1038/srep19930
[16]	Matsubara D, Shoda K, Kubota T, et al. Preoperative total cholesterol-lymphocyte score as a novel immunonutritional predictor of survival in gastric cancer[J]. Langenbecks Arch Surg, 2019, 404(6): 743-752. doi: 10.1007/s00423-019-01824-8
[17]	Nam SY, Park BJ, Nam JH, et al. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development[J]. Gastrointest Endosc, 2019, 90(3): 448-456. doi: 10.1016/j.gie.2019.04.232
[18]	Soran H, Schofield JD, Durrington PN. Antioxidant properties of HDL [J]. Front Pharmacol, 2015, 6: 222.